Treatment of cancer patients has become challenging when large parts of hospital services need to be shut down as a consequence of a local COVID-19 outbreak that requires rapid containment measures, in conjunction with the shifting of priorities to vital services. Reports providing conceptual frameworks and first experiences on how to maintain a clinical hematology/oncology service during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic are scarce. Here, we report our first 8 weeks of experience after implementing a procedural plan at a hematology/oncology unit with its associated cancer center at a large academic teaching hospital in Germany. By strictly separating team workflows and implementing vigorous testing for SARS-CoV-2 infections for all patients and staff members irrespective of clinical symptoms, we were successful in maintaining a comprehensive hematology/oncology service to allow for the continuation of treatment for our patients. Notably, this was achieved without introducing or further transmitting SARS-CoV-2 infections within the unit and the entire center. Although challenging, our approach appears safe and feasible and may help others to set up or optimize their procedures for cancer treatment or for other exceedingly vulnerable patient cohorts.
Oncol Res Treat

中文翻译：

---

SARS-CoV-2大流行期间在三级护理中心维持成人血液学/肿瘤学服务：八周的经验和新实施的程序计划

当由于局部COVID-19爆发需要快速遏制措施以及将重点转移到重要服务上而需要关闭大部分医院服务时，癌症患者的治疗就变得充满挑战。在严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2）大流行期间，缺乏如何保持临床血液学/肿瘤学服务的概念框架和初步经验的报告很少。在这里，我们报告了我们在德国一家大型学术教学医院的血液/肿瘤科及其相关癌症中心实施程序计划后的前8周经验。通过严格区分团队工作流程并针对所有患者和工作人员，无论临床症状如何，对SARS-CoV-2感染进行严格的测试，我们成功地维持了全面的血液学/肿瘤学服务，以使我们的患者能够继续接受治疗。值得注意的是，这是在没有在单位和整个中心内引入或进一步传播SARS-CoV-2感染的情况下实现的。尽管具有挑战性，但我们的方法似乎安全可行，可以帮助其他人建立或优化他们的癌症治疗程序或其他极其脆弱的患者队列。
昂科尔水疗中心